Ardent Health
ARDT

Ardent Health (ARDT) earnings history

Most recent quarter

Period end
Jun 30, 2026
EPS surprise
−33.96%
Revenue
$1.6B
Reported
Aug 4, 2026

Ardent Health reported Q2 2026 results on August 4, 2026. EPS was $0.12, below the $0.18 estimate by 33.96%. Revenue was about $1.6 billion, 2.05% above the consensus. Compared with Q2 2025, EPS fell about 77% from $0.52, while revenue was about $1.6 billion in both quarters.

The record here is short, with nine quarters starting at Q2 2024. Quarterly revenue has stayed between about $1.4 billion and $1.6 billion throughout. Earnings have swung more. The only full year in the table, 2025, totaled $0.96 per share. It included a loss of $0.17 per share in Q3 2025, the only loss shown and 140.61% below the estimate. The high was $0.81 in Q4 2024. The first half of 2026 adds up to $0.40 per share, against $0.81 a year earlier. Ardent beat the EPS estimate six times in the nine quarters shown.

Ardent reported Q3 results on November 6, 2024 and November 12, 2025. That points to early or mid-November 2026 for the next report. It will show how Q3 2026 compares with the loss a year earlier, and whether revenue holds near $1.6 billion.

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Aug 4, 2026$0.18$0.12−33.96%$1.6BSEC
Q1 2026May 5, 2026$0.19$0.28+46.75%$1.6BSEC
Q4 2025Mar 4, 2026$0.32$0.32+1.04%$1.6BSEC
Q3 2025Nov 12, 2025$0.42−$0.17−140.61%$1.6BSEC
Q2 2025Aug 5, 2025$0.23$0.52+129.99%$1.6BSEC
Q1 2025May 6, 2025$0.20$0.29+44.28%$1.5BSEC
Q4 2024Feb 26, 2025$0.48$0.81+70.06%$1.6BSEC
Q3 2024Nov 6, 2024$0.31$0.19−38.43%$1.4BSEC
Q2 2024Aug 14, 2024$0.31$0.34+10.86%$1.5BSEC

Quarterly revenue

Q2 2024
$1.5B
Q3 2024
$1.4B
Q4 2024
$1.6B
Q1 2025
$1.5B
Q2 2025
$1.6B
Q3 2025
$1.6B
Q4 2025
$1.6B
Q1 2026
$1.6B
Q2 2026
$1.6B

Frequently asked questions

  • When did Ardent Health (ARDT) last report earnings?

    Ardent Health last reported on Aug 4, 2026, covering fiscal Q2 2026.

  • Did ARDT beat earnings estimates?

    No. Ardent Health reported EPS of $0.12 for Q2 2026 against a $0.18 estimate — a 33.96% miss.

  • How much revenue did ARDT report last quarter?

    Ardent Health reported $1.6B in revenue for Q2 2026, against a consensus estimate of $1.6B.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.